Guj. Terce Labs.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE499G01013
NSEID:
BSEID: 524314
View on BSE

INR

31.55

-1.51 (-4.57%)

BSENSE

Mar 30

BSE+NSE Vol: 7.84 k

{
  "main_header": {
    "sid": 890385,
    "name": "Guj. Terce Labs.",
    "stock_name": "Guj. Terce Labs.",
    "full_name": "Gujarat Terce Laboratories Ltd",
    "name_url": "stocks-analysis/guj-terce-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.55",
    "chg": -1.51,
    "chgp": "-4.57%",
    "dir": -1,
    "prev_price": "33.06",
    "mcapval": "25.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524314,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE499G01013",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "7.84 k",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/guj-terce-labs-890385-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Gujarat Terce Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-falls-to-52-week-low-of-rs29-3925646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3925646.png",
        "date": "2026-03-30 15:16:06",
        "description": "For the fifth consecutive session, Gujarat Terce Laboratories Ltd closed lower, slipping to a fresh 52-week low of Rs 29 on 30 Mar 2026. This marks a steep 21.11% decline over the past five days amid heightened volatility and persistent selling pressure."
      },
      {
        "title": "Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-hits-52-week-low-amidst-continued-downtrend-3919360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3919360.png",
        "date": "2026-03-27 11:47:48",
        "description": "Despite a broader market rally, Gujarat Terce Laboratories Ltd has plunged to a fresh 52-week low of Rs 33 on 27 Mar 2026, marking a steep 43.45% decline over the past year and underscoring persistent headwinds for this micro-cap pharmaceutical player."
      },
      {
        "title": "Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-falls-to-52-week-low-of-rs3485-3916118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3916118.png",
        "date": "2026-03-25 11:07:24",
        "description": "While the broader market surged with the Sensex climbing over 900 points, Gujarat Terce Laboratories Ltd has continued its downward trajectory, hitting a fresh 52-week low of Rs 34.85 on 25 Mar 2026. The stock has now declined for three consecutive sessions, shedding nearly 13% in that period, markedly underperforming its sector and the wider market."
      },
      {
        "title": "Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-falls-to-52-week-low-of-rs3506-3910892",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3910892.png",
        "date": "2026-03-24 15:48:53",
        "description": ""
      },
      {
        "title": "Gujarat Terce Laboratories Ltd Hits 52-Week Low Amidst Weak Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-hits-52-week-low-amidst-weak-financial-metrics-3898519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3898519.png",
        "date": "2026-03-18 10:00:27",
        "description": "Gujarat Terce Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.36.06 today, marking a significant downturn amid ongoing market pressures and company-specific factors. This new low reflects a continuation of the stock’s underperformance relative to the broader market and its sector peers."
      },
      {
        "title": "Gujarat Terce Laboratories Falls 3.80%: Margin Pressures and Flat Quarterly Results Weigh",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-falls-380-margin-pressures-and-flat-quarterly-results-weigh-3826250",
        "imagepath": "",
        "date": "2026-02-07 14:07:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at ₹44.32, declines 3.65% amid broader market weakness</p>\n                    <p><strong>3 Feb:</strong> Minor decline of 0.65% despite Sensex rallying 2.63%</p>\n                    <p><strong>4 Feb:</strong> Stock rebounds 2.29% following Q3 results revealing profitability collapse</p>\n                    <p><strong>5 Feb:</strong> Sharp 5.40% drop on flat quarterly performance and margin pressure news</p>\n                    <p><strong>6 Feb:</strong> Recovery of 3.85% on low volume, closing at ₹44.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "Gujarat Terce Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-terce-laboratories-ltd-is-rated-strong-sell-3825718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratTerceLab_mojoScore_3825718.png",
        "date": "2026-02-07 10:10:32",
        "description": "Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Gujarat Terce Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gujarat-terce-laboratories-ltd-latest-results-good-or-bad-3822903",
        "imagepath": "",
        "date": "2026-02-05 19:26:49",
        "description": "Gujarat Terce Laboratories Ltd's latest financial results indicate significant operational challenges, particularly marked by margin compression and inconsistent profitability. In the quarter ended December 2025, the company reported a net sales decline of 4.95% compared to the previous quarter, which contrasts with a growth of 19.17% in September 2025. This decline in sales is concerning, especially as it follows a period of notable revenue fluctuations.\n\nThe standalone net profit for the December quarter also reflected a substantial decrease of 45.71% compared to the previous quarter, where there was an extraordinary increase of 3,600.00%. This sharp decline raises questions about the sustainability of profitability and operational efficiency. The operating profit margin, which fell to 9.28%, represents a decrease of 5.41% from the prior quarter, further highlighting the challenges in managing costs effec..."
      },
      {
        "title": "Gujarat Terce Laboratories Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-reports-flat-quarterly-performance-amid-margin-pressures-3821519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratTerceLab_fintrenddot_3821519.png",
        "date": "2026-02-05 08:00:24",
        "description": "Gujarat Terce Laboratories Ltd has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s overall financial trend score has deteriorated sharply, reflecting challenges in sustaining revenue growth and margin expansion in a competitive pharmaceutical sector."
      }
    ],
    "total": 182,
    "sid": "890385",
    "stock_news_url": "https://www.marketsmojo.com/news/gujarat-terce-laboratories-890385"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Detailed disclosure is attached.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Trading Approval For 371000 Equity Shares Of Face Value Rs. 10/- Each Allotted Pursuant To Conversion Of Warrants Issued On Preferential Basis From BSE Limited",
      "datetime": "24-Feb-2026",
      "details": "Detailed disclosure attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Feb-2026",
      "details": "Detailed disclosure as attached.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Five Consecutive Losses Push Gujarat Terce Laboratories Ltd to a New 52-Week Low

2026-03-30 15:16:06

For the fifth consecutive session, Gujarat Terce Laboratories Ltd closed lower, slipping to a fresh 52-week low of Rs 29 on 30 Mar 2026. This marks a steep 21.11% decline over the past five days amid heightened volatility and persistent selling pressure.

Read full news article

Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-27 11:47:48

Despite a broader market rally, Gujarat Terce Laboratories Ltd has plunged to a fresh 52-week low of Rs 33 on 27 Mar 2026, marking a steep 43.45% decline over the past year and underscoring persistent headwinds for this micro-cap pharmaceutical player.

Read full news article

Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-25 11:07:24

While the broader market surged with the Sensex climbing over 900 points, Gujarat Terce Laboratories Ltd has continued its downward trajectory, hitting a fresh 52-week low of Rs 34.85 on 25 Mar 2026. The stock has now declined for three consecutive sessions, shedding nearly 13% in that period, markedly underperforming its sector and the wider market.

Read full news article

Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-24 15:48:53

Read full news article

Gujarat Terce Laboratories Ltd Hits 52-Week Low Amidst Weak Financial Metrics

2026-03-18 10:00:27

Gujarat Terce Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.36.06 today, marking a significant downturn amid ongoing market pressures and company-specific factors. This new low reflects a continuation of the stock’s underperformance relative to the broader market and its sector peers.

Read full news article

Gujarat Terce Laboratories Falls 3.80%: Margin Pressures and Flat Quarterly Results Weigh

2026-02-07 14:07:36

Key Events This Week

2 Feb: Stock opens at ₹44.32, declines 3.65% amid broader market weakness

3 Feb: Minor decline of 0.65% despite Sensex rallying 2.63%

4 Feb: Stock rebounds 2.29% following Q3 results revealing profitability collapse

5 Feb: Sharp 5.40% drop on flat quarterly performance and margin pressure news

6 Feb: Recovery of 3.85% on low volume, closing at ₹44.25

Week Open

<...

Read full news article

Gujarat Terce Laboratories Ltd is Rated Strong Sell

2026-02-07 10:10:32

Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Gujarat Terce Laboratories Ltd latest results good or bad?

2026-02-05 19:26:49

Gujarat Terce Laboratories Ltd's latest financial results indicate significant operational challenges, particularly marked by margin compression and inconsistent profitability. In the quarter ended December 2025, the company reported a net sales decline of 4.95% compared to the previous quarter, which contrasts with a growth of 19.17% in September 2025. This decline in sales is concerning, especially as it follows a period of notable revenue fluctuations. The standalone net profit for the December quarter also reflected a substantial decrease of 45.71% compared to the previous quarter, where there was an extraordinary increase of 3,600.00%. This sharp decline raises questions about the sustainability of profitability and operational efficiency. The operating profit margin, which fell to 9.28%, represents a decrease of 5.41% from the prior quarter, further highlighting the challenges in managing costs effec...

Read full news article

Gujarat Terce Laboratories Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-02-05 08:00:24

Gujarat Terce Laboratories Ltd has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s overall financial trend score has deteriorated sharply, reflecting challenges in sustaining revenue growth and margin expansion in a competitive pharmaceutical sector.